Your Location：
Home >
Browse articles >
Mechanism of Action of Coptidis Rhizoma and Ophiopogonis Radix in Delaying Diabetic Nephropathy Based on EGFR/PI3K/Akt Signaling Pathway
Updated：2024-09-12
Previous|Next

    • Mechanism of Action of Coptidis Rhizoma and Ophiopogonis Radix in Delaying Diabetic Nephropathy Based on EGFR/PI3K/Akt Signaling Pathway

    • “The latest research found that Coptis chinensis - Ophiopogon japonicus can alleviate the renal damage of diabetes nephropathy rats, which may play a role by regulating EGFR/PI3K/Akt signaling pathway.”
    • LI Shaoyu , GONG Man , LI Qiufang , DAI Liping , WANG Guiqun , YANG Qiuchen , ZHANG Qiongqiong , XU Erping , LIU Yalin
    • Chinese Journal of Experimental Traditional Medical Formulae Vol. 30, Issue 20, Pages: 22-29(2024)

    • DOI： 10.13422/j.cnki.syfjx.20241202     

      CLC：

    Scan QR Code

  •  
  •  

  • AI Introduction

  • Full Text(HTML)

  • Figs( 3 ) Tabs( 6 )

  • References

  • Publication Info

  • Metrics

507

Views

482

Downloads

4

CSCD

Alert me when the article has been cited
Submit
Tools
  • BibTeXDownload
  • EndnoteDownload
  • RefMan Download
  • NoteExpressDownload
  • NoteFirstDownload

Related Articles

Analysis of Volatile Component Variations in Coptidis Rhizoma Processed with Euodiae Fructus Juice by HS-SPME-GC-MS Combined with Chemometrics and ROAV
Establishment of Objective Indicators and Evaluation System for "Excellent Shape and High Quality" Characteristics of Authentic Ophiopogonis Radix
Pathogenesis of Diabetic Nephropathy and Traditional Chinese Medicine Intervention Based on Signaling Pathways： A Review
Effect of Jianpi Qinghua Granules on Blood Glucose Fluctuations and Skeletal Muscle Mass and Function in Newly Diagnosed Overweight/Obese Type 2 Diabetes Patients with Qi-Yin Deficiency Syndrome
Flavonoids Intervene in Diabetic Nephropathy by Regulating TGF-β/Smad Signaling Pathway： A Review

Related Author

YAN Lin
WANG Yun
LI Puling
MENG Lingbang
JIA Zhe
LI Ying
LIU Ying
JIN Min

Related Institution

State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs， Institute of Chinese Materia Medica，China Academy of Chinese Medical Sciences
Beijing Jiakesi New Drug Development Co. Ltd.
Guang'anmen Hospital， China Academy of Chinese Medical Sciences
Experimental Research Center， China Academy of Chinese Medical Sciences
National Resource Center for Chinese Materia Medica， China Academy of Chinese Medical Sciences